Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Transplantation. 2017 Jan;101(1):182–190. doi: 10.1097/TP.0000000000001080

Figure 3. Adjusted hazard ratios for combinations of normal and elevated BNP and cTnI.

Figure 3

Patients were stratified by BNP and hs-cTnI values below and above the clinical cutoff, i.e. 100 pg/mL for BNP and 26.2 ng/L for hs-cTnI. Hazard ratios and their 95% confidence intervals for adverse outcomes are shown.